Rubicon Organics Posts Record Revenue but Faces Near-Term Margin Pressures
Event summary
- Rubicon Organics reported $59.5M in net revenue for 2025, a 22% increase from 2024.
- Adjusted EBITDA rose to $5.0M (25% YoY), with operational income turning positive at $1.8M.
- Cascadia facility completed first harvests in February 2026, expected to boost capacity by 40%.
- Q4 2025 revenue hit $16.5M (16% QoQ growth), but margins face near-term pressure from Cascadia ramp-up.
- Company secured a $3M loan at 6.79% interest for facility expansion.
The big picture
Rubicon Organics' record revenue and operational turnaround underscore its leadership in Canada's premium cannabis segment, but the rapid scaling of Cascadia introduces near-term execution risks. The company's ability to leverage its genetics library and international expansion strategy will determine whether it can sustain margin improvements amid competitive pressures.
What we're watching
- Scale vs. Margins
- Whether Cascadia's operationalization can offset near-term margin compression.
- International Expansion
- The pace at which Rubicon can monetize its premium brands globally.
- Market Recovery
- How B.C. market softness impacts early 2026 performance.
Related topics